182 related articles for article (PubMed ID: 27965049)
1. Clinical efficacy of Rong-Yang-Jyh-Gan-Tang on patients with chronic hepatitis C: A double-blinded randomized placebo-controlled crossover study.
Chen FP; Chang CM; Wu TP; Yang JL; Kung YY; Huang YH; Su CW; Lan KH; Chiang SC; Hwang SJ
J Ethnopharmacol; 2017 Jan; 196():1-8. PubMed ID: 27965049
[TBL] [Abstract][Full Text] [Related]
2. A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients.
Deng G; Kurtz RC; Vickers A; Lau N; Yeung KS; Shia J; Cassileth B
J Ethnopharmacol; 2011 Jun; 136(1):83-7. PubMed ID: 21527335
[TBL] [Abstract][Full Text] [Related]
3. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
[TBL] [Abstract][Full Text] [Related]
4. Frequency and pattern of Chinese herbal medicine prescriptions for chronic hepatitis in Taiwan.
Chen FP; Kung YY; Chen YC; Jong MS; Chen TJ; Chen FJ; Hwang SJ
J Ethnopharmacol; 2008 Apr; 117(1):84-91. PubMed ID: 18321671
[TBL] [Abstract][Full Text] [Related]
5. Randomized double blind placebo-controlled trial of a Chinese herbal therapy (CH100) in chronic hepatitis C.
Mollison L; Totten L; Flexman J; Beaman M; Batey R
J Gastroenterol Hepatol; 2006 Jul; 21(7):1184-8. PubMed ID: 16824073
[TBL] [Abstract][Full Text] [Related]
6. [Syndrome distribution among patients with chronic hepatitis C and interventions of integrated traditional Chinese and Western medicine: study protocol].
Nie HM; Gao YQ; Chen JJ
Zhong Xi Yi Jie He Xue Bao; 2011 Apr; 9(4):365-73. PubMed ID: 21486548
[TBL] [Abstract][Full Text] [Related]
7. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
8. Amantadine therapy for chronic hepatitis C.
Smith JP; Riley TR; Devenyi A; Bingaman SI; Kunselman A
J Gen Intern Med; 2004 Jun; 19(6):662-8. PubMed ID: 15209605
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.
Samuel D; Bizollon T; Feray C; Roche B; Ahmed SN; Lemonnier C; Cohard M; Reynes M; Chevallier M; Ducerf C; Baulieux J; Geffner M; Albrecht JK; Bismuth H; Trepo C
Gastroenterology; 2003 Mar; 124(3):642-50. PubMed ID: 12612903
[TBL] [Abstract][Full Text] [Related]
10. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of traditional Chinese medicine for cooling blood and eliminating toxins and strengthening and purifying spleen in the treatment of refractory hepatitis C.
Jing FD; Ma ZG; Liu YB; Yan G
J Biol Regul Homeost Agents; 2016; 30(1):247-53. PubMed ID: 27049099
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C Viral Kinetic Changes in a Retrospective Cohort Study of Chronic Hepatitis C Virus Egyptian Patients on Pegylated Interferon and Ribavirin Therapy.
Esmat GE; Al Akel W; Abdel Aziz RA; Al Sayed Taha A; Sabry D; Rashed LA; Mostafa A; El Kazaz AY; Ahmed SH
J Interferon Cytokine Res; 2016 Mar; 36(3):149-58. PubMed ID: 26982165
[TBL] [Abstract][Full Text] [Related]
13. [Effects of Xiaopi Yishen herbal extract granules in treatment of fatigue-predominant subhealth due to liver-qi stagnation and spleen-qi deficiency: a prospective, randomized, placebo-controlled and double-blind clinical trial].
Wang TF; Xue XL; Zhang YJ; Han P; Li Z; Wang WP; Xing JM; Wang QB; Tang Y; Li L; Wang JJ; Li GR; Ji SL; Wu LX; Zhao Y; Wu XY; Zhao RS
Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):515-24. PubMed ID: 21565137
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.
Lee MH; Kim YM; Kim SG
Int J Clin Pharmacol Ther; 2012 Nov; 50(11):778-86. PubMed ID: 22943930
[TBL] [Abstract][Full Text] [Related]
15. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of Qurse-e-istisqua in chronic hepatitis C infection: an exploratory study.
Rehan HS; Chopra D; Yadav M; Wardhan N; Manak S; Siddiqui KM; Aslam M
Indian J Pharmacol; 2015; 47(1):72-9. PubMed ID: 25821315
[TBL] [Abstract][Full Text] [Related]
17. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
[TBL] [Abstract][Full Text] [Related]
18. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study.
Papastergiou V; Stampori M; Lisgos P; Pselas C; Prodromidou K; Karatapanis S
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):798-805. PubMed ID: 23395996
[TBL] [Abstract][Full Text] [Related]
19. Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.
Soresi M; Tripi S; Franco V; Giannitrapani L; Alessandri A; Rappa F; Vuturo O; Montalto G
Liver Int; 2006 Nov; 26(9):1119-25. PubMed ID: 17032413
[TBL] [Abstract][Full Text] [Related]
20. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
